The Navigator Project
NAV
Navigator-Enhanced Case Management for HIV-Infected Jail Inmates Reentering the Community
1 other identifier
interventional
271
1 country
1
Brief Summary
Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail. Two thirds of those released with HIV-focused discharge planning are reincarcerated within one year. More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance use disorders at the time of detention. While some community-based services exist, there remains a critical need to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jail. The Navigator Project is a five-year randomized study that will test the effectiveness of an intensive enhanced case management intervention to reduce sex and drug-related HIV transmission risk; increase HIV medication adherence; reduce drug dependence; and reduce reincarceration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Feb 2010
Longer than P75 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 1, 2014
CompletedFirst Posted
Study publicly available on registry
April 8, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedJune 16, 2015
June 1, 2015
4.3 years
April 1, 2014
June 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
substance use
change from baseline in self-reported drug and alcohol use, measured by a survey tool, and actual use of five drugs (methamphetamine, cocaine, tetrahydrocannabinol, opiates, and benzodiazepines), measured by a urine screen, at three time points each
2 months, 6 months, 12 months
recidivism
number of times re-detained during the twelve-month study period, collected from jail records
12 months
Secondary Outcomes (2)
sexual risk behavior
2 months, 6 months, 12 months
adherence to HIV medications
2 months, 6 months, 12 months
Other Outcomes (3)
housing
2 months, 6 months, 12 months
medical coverage
2 months, 6 months,12 months
needle use
2 months, 6 months, 12 months
Study Arms (2)
FAP counseling
ACTIVE COMPARATORControl arm utilizing the standard of care: access to services provided by the Forensic AIDS Project for up to 90 days after release
Navigator enhanced case-management
EXPERIMENTALExperimental arm: access to Navigator enhanced case-management services for one year after release
Interventions
Patient navigators are non-clinical, paraprofessional peers who are HIV-infected and have lifetime histories of detention and substance abuse. Working with the patient, they facilitate adherence to a comprehensive care plan designed to address clients' multiple risks and needs. Patients have access to Navigator services for one year after study enrollment.
The Forensics AIDS Project provides primary care to HIV-infected detainees, as well as up to 90 post-release case-management services which include discharge planning.
Eligibility Criteria
You may qualify if:
- Detention in the San Francisco jail system
- Confirmed HIV infection
- Lifetime history of ever having met standardized criteria for drug or alcohol addiction
- Likely release back into San Francisco without transfer to another facility
- Agreement to work with Forensic AIDS Project to plan post-release care
- Able and willing to provide informed consent
- Not scheduled for release within 36 hours
You may not qualify if:
- Undocumented HIV status
- Inability to speak English or Spanish
- Unable or unwilling to provide informed consent
- Not under routine level of jail security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tenderloin Clinical Research Foundation
San Francisco, California, 94102, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janet J Myers, PhD, MPH
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2014
First Posted
April 8, 2014
Study Start
February 1, 2010
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
June 16, 2015
Record last verified: 2015-06